Home > Financial Ratios > JUBILANT PHARMOVA

JUBILANT PHARMOVA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for JUBILANT PHARMOVA
Please provide your vote to see the results

JUBILANT PHARMOVA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 19.03-30.24-17.43-10.80-10.67

What is the latest Core EBITDA Growth ratio of JUBILANT PHARMOVA ?

The latest Core EBITDA Growth ratio of JUBILANT PHARMOVA is 19.03 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202419.03
Mar2023-30.24
Mar2022-17.43
Mar2021-10.80
Mar2020-10.67

How is Core EBITDA Growth of JUBILANT PHARMOVA Trending?

Years Core EBITDA Growth % Change
Mar2024 19.03
Positive
Mar2023 -30.24
Negative
Mar2022 -17.43
Negative
Mar2021 -10.8
Negative
Mar2020 -10.67 -

Other Financial Ratios of JUBILANT PHARMOVA


Compare Core EBITDA Growth ratio of peers of JUBILANT PHARMOVA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JUBILANT PHARMOVA ₹14,576.0 Cr 3.9% 5.8% 41.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,123.0 Cr 0.2% 1% 6.3% Stock Analytics
DIVIS LABORATORIES ₹152,844.0 Cr 6.8% 1.6% 53.3% Stock Analytics
CIPLA ₹120,860.0 Cr 4.4% 2.9% 4.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,020.0 Cr -0.7% 4% 25.1% Stock Analytics
DR REDDYS LABORATORIES ₹96,755.1 Cr 4.6% 4.9% -6.2% Stock Analytics


JUBILANT PHARMOVA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JUBILANT PHARMOVA

3.9%

5.8%

41.7%

SENSEX

5.3%

4%

3.2%


You may also like the below Video Courses